Literature DB >> 35865775

Legionella pneumonia immediately after recovery from COVID-19.

Daisuke Jingu1, Hiroshi Takahashi1, Satoshi Ubukata1, Hiroshi Watanabe1, Akira Horii2.   

Abstract

We experienced a patient with Legionella pneumonia developing immediately after discharge from COVID-19 recovery. Antibiotic treatment was successful. The source of Legiolella infection was proven to be bathtub water in this case. It is very important to accurately detect pathogens, particularly in the time of pandemics such as COVID-19.
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID‐19; Legionella pneumonia; Legionella pneumophila; SARS‐CoV‐2; serogroup 5

Year:  2022        PMID: 35865775      PMCID: PMC9295677          DOI: 10.1002/ccr3.6090

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


CLINICAL IMAGE

An 83‐year‐old woman visited our emergency department with consciousness disorder, high fever, and hypoxemia 5 days after healing and discharge from COVID‐19. Examination data on Day 1 revealed high inflammatory responses. Chest X‐ray and CT (Figure 1A) revealed features of severe pneumonia which are obviously distinct from those at COVID‐19. The SARS‐CoV‐2 antigen was negative, but urinary Legionella antigen was positive, and Legionella pneumophila serogroup 5 was detected from her sputum. Legionella pneumonia was diagnosed. Levofloxacin was effective for the Legionella pneumonia, but secondary bacterial pneumonia developed; other antibiotic therapy was successful. She was transferred to a long‐term hospital on Day 68 (Figure 1B). Legionella pneumophila was detected in her daily reused bathtub water (Figure 2); this very common Japanese lifestyle in Japan can be a hotbed of Legionella infection. Increasing focus on Legionnaires' disease is needed in association with relaxation of lockdown as the COVID‐19 pandemic recedes. Legionellosis after influenza is reported, but this is the first case of Legionella pneumonia after COVID‐19 infection. Patients should be followed up for subsequent infections after discharge.
FIGURE 1

Clinical course of patient with images. (A) Images of plain X‐ray and CT scan on indicated date with percutaneous oxygen saturation (SpO2), CRP, and body temperature (BT). (B) Clinical course of CRP with treatments. This patient was hospitalized with COVID‐19 between Day −14 and Day −5, then, re‐hospitalized on Day 1 with Legionnaire's disease. DEX, dexamethasone; LVFX, levofloxacin; TAZ/PIPC, tazobactam/piperacillin; MEPM, meropenem.

FIGURE 2

(A) Bathtub filled with reused water in this patient's home. (B) Gimenez staining disclosed Legionella pneumophila in both patient's sputum and bathtub water. Staining results from bathtub water are shown.

Clinical course of patient with images. (A) Images of plain X‐ray and CT scan on indicated date with percutaneous oxygen saturation (SpO2), CRP, and body temperature (BT). (B) Clinical course of CRP with treatments. This patient was hospitalized with COVID‐19 between Day −14 and Day −5, then, re‐hospitalized on Day 1 with Legionnaire's disease. DEX, dexamethasone; LVFX, levofloxacin; TAZ/PIPC, tazobactam/piperacillin; MEPM, meropenem. (A) Bathtub filled with reused water in this patient's home. (B) Gimenez staining disclosed Legionella pneumophila in both patient's sputum and bathtub water. Staining results from bathtub water are shown.

AUTHOR CONTRIBUTIONS

DJ, HT, SU, and HW substantially contributed to the diagnosis and clinical care of the patient. DJ wrote the draft of the manuscript, and DJ and AH critically revised it for important intellectual content.

FUNDING INFORMATION

None.

CONFLICT OF INTEREST

None declared.

CONSENT

Written informed consent was obtained from the patient to publish this report in accordance with the journal's patient consent policy, and the study was approved by the Ethics Committee in Saka General Hospital (No. 21–9‐21).
  2 in total

Review 1.  Legionnaire's Disease and Influenza.

Authors:  Eleni E Magira; Sryros Zakynthinos
Journal:  Infect Dis Clin North Am       Date:  2017-03       Impact factor: 5.982

2.  Co-infection with Legionella and SARS-CoV-2, France, March 2020.

Authors:  Camille Allam; Alexandre Gaymard; Ghislaine Descours; Christophe Ginevra; Laurence Josset; Maud Bouscambert; Laetitia Beraud; Marine Ibranosyan; Camille Golfier; Arnaud Friggeri; Bruno Lina; Christine Campèse; Florence Ader; Sophie Jarraud
Journal:  Emerg Infect Dis       Date:  2021-09-01       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.